Dermal Advanced REACH Tool (dART)-Development of a Dermal Exposure Model for Low-Volatile Liquids.


Journal

Annals of work exposures and health
ISSN: 2398-7316
Titre abrégé: Ann Work Expo Health
Pays: England
ID NLM: 101698454

Informations de publication

Date de publication:
24 07 2019
Historique:
received: 24 01 2018
revised: 09 11 2018
accepted: 04 12 2018
pubmed: 10 3 2019
medline: 6 5 2020
entrez: 10 3 2019
Statut: ppublish

Résumé

This article describes the development of a mechanistic model for underpinning the dermal Advanced REACH Tool (dART), an extension of the existing ART model and its software platform. It was developed for hand exposure to low volatile liquids (vapour pressure ≤ 10 Pa at 20°C) including solids-in-liquid products. The model is based on an existing conceptual dermal source-receptor model that has been integrated into the ART framework. A structured taxonomy of workplace activities referred to as activity classes are adopted from ART.  Three key processes involved in mass transport associated with dermal exposure are applied, i.e. deposition, direct emission and contact, and transfer. For deposition, the model adopts all the relevant modifying factors (MFs) applied in ART. In terms of direct emission and contact (e.g. splashes) and transfer (e.g. hand-surface contacts), the model defines independent principal MFs, i.e. substance-related factors, activity-related factors, localized- and dispersion control and exposed surface area of the hands. To address event-based exposures as much as possible, the model includes crucial events during an activity (e.g. hand immersions) and translates objective information on tools and equipment (manual or automated) to probable events (e.g. splashes) and worker behaviours (e.g. surface contacts). Based on an extensive review of peer-reviewed literature and unpublished field studies, multipliers were assigned to each determinant and provide an approximated (dimensionless) numerical value. In the absence of (sufficient) evidence, multipliers were assigned to determinants based on assumptions made during discussions by experts in the consortium. A worked example is presented to illustrate the calculation of hand exposure for a specific scenario. The dART model is not yet implemented in the ART software platform, and a robust validation of the model is necessary to determine its predictive ability. With advancing knowledge on dermal exposure and its determinants, this model will require periodic updates and refinements, in addition to further expansion of the applicability domain of the model.

Identifiants

pubmed: 30851094
pii: 5372723
doi: 10.1093/annweh/wxy106
doi:

Substances chimiques

Volatile Organic Compounds 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

624-636

Informations de copyright

© The Author(s) 2019. Published by Oxford University Press on behalf of the British Occupational Hygiene Society.

Auteurs

Henk A Goede (HA)

Netherlands Organisation for Applied Scientific Research (TNO), Risk Assessment for Products in Development (RAPID), The Netherlands.

Kevin McNally (K)

Health and Safety Executive (HSE), Harpur Hill, Buxton, UK.

Jean-Philippe Gorce (JP)

Health and Safety Executive (HSE), Harpur Hill, Buxton, UK.

Hans Marquart (H)

Triskelion BV, The Netherlands.

Nick D Warren (ND)

Health and Safety Executive (HSE), Harpur Hill, Buxton, UK.

Wouter Fransman (W)

Netherlands Organisation for Applied Scientific Research (TNO), Risk Assessment for Products in Development (RAPID), The Netherlands.

Martin Tischer (M)

Federal Institute for Occupational Safety and Health (BAuA), Dortmund, Germany.

Jody Schinkel (J)

Netherlands Organisation for Applied Scientific Research (TNO), Risk Assessment for Products in Development (RAPID), The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH